Takeda approval ushers in new wave of sleep drugs
An FDA nod mostly clears the way for Orzeyful to enter, by Wall Street estimates, a multibillion-dollar market for drugs that boost “orexin” proteins.
Read the full article on the original site.
Read Full Article